Monday, January 24, 2011

Biotech/Pharma Stocks News; UV Flu Technologies (OTCBB: UVFT) Signs First Distributor Exclusive to Personal Esthetics Sector

CENTERVILLE, MA � January 24, 2011 (Investorideas.com Newswire) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") announced today that the Company's flagship product, the ViraTech UV-400 indoor air purifier, is now being distributed through the Perfect Touch Beauty Network ("Perfect Touch") targeting the growing need for improved air quality at beauty salons across the country.
The driving force behind Perfect Touch is its industry renowned principal Debi Nemeth, a respected innovator, distributor and trainer headquartered in Colorado, who works with one of the top nail salon supply companies in the country, training and supplying over 200 nail technicians annually in Colorado, and from surrounding states. The nail salon supply company distributes products, trains estheticians and management, plus licenses hundreds of branded locations throughout the Country and around the globe. Ms. Nemeth trains new and current nail salon owners, particularly with respect to new products and technologies, while also providing an esthetics training curriculum for three colleges within Colorado.
"I not only train and distribute nail products, I'm an owner of a salon, which gives me the ability to test all of the products I distribute, as we only use the best," said Ms. Nemeth. "As a salon owner as well as an educator it was impressive to experience such immediate results. When we brought the ViraTech UV-400 into our salon, our clients couldn't believe the difference! They actually noticed there was no smell in the salon whatsoever, other than a fresh, outdoor quality. Our customers really appreciate that we value their health and my staff has not had one sick day since we brought in the device. I recommend it as an essential piece of equipment for any salon owner, as it pays for itself within weeks by bringing in more business, while also reducing absenteeism."
"Salons all over the Country are already starting to experience regulations on hygiene, and air quality inside their businesses," said John Lennon, President of UV Flu Technologies. "Product trainers and distributors alike that have tried our product truly think it is a game changer, as it protects employees, as well as customers, from toxic fumes and noxious odors, while also keeping them healthy from the spread of airborne bacteria. The units are increasing salon business, while dramatically decreasing the number of complaints from neighbors, particularly with respect to operations located within malls. We think Ms. Nemeth will be incredibly helpful in educating salon owners that this is a product that really works."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector (over $7.7 billion in 2008). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.) The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. For more information, visit: www.uvflutech.com. For sales: www.puravair.com.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Contact:
Investor Information:
Geaux IR Services, Inc.
Toll-Free: 1-888-355-8838
investors@uvflutech.com
SOURCE: UV Flu Technologies, Inc.
UV Flu Technologies (OTCBB: UVFT) is a showcase biotech stock on Investorideas.com (please read disclosure and disclaimers)
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/UVFT/

Request info:
http://www.investorideas.com/Resources/Newsletter.asp

No comments: